7. Endocrine disruptors: state of play following the Court judgment of 16 December 2015 (motions for resolutions tabled)

Commission statement: Endocrine disruptors: state of play following the Court judgment of 16 December 2015 (2016/2747(RSP))

The debate had been held on 25 May 2016 (minutes of 25.5.2016, item 19).

Motions for resolutions to wind up the debate tabled under Rule 123(2):

—   Matthias Groote, on behalf of the S&D Group, and Bas Eickhout, on behalf of the Verts/ALE Group, on endocrine disruptors: state of play following the Court of Justice judgment of 16 December 2015 (2016/2747(RSP)) (B8-0733/2016);

—   Sylvie Goddyn, on behalf of the ENF Group, on endocrine disruptors: state of play following the Court of Justice judgment of 16 December 2015 (2016/2747(RSP)) (B8-0734/2016);

—   Anja Hazekamp, Kateřina Konečná, Lynn Boylan, Stefan Eck, Merja Kyllönen, Marie-Christine Vergiat, Marisa Matias, Paloma López Bermejo, Sofia Sakorafa, Maria Lidia Senra Rodríguez, Miguel Urbán Crespo, Lola Sánchez Caldentey, Tania González Peñas, Xabier Benito Ziluaga, Estefanía Torres Martínez, Ángela Vallina, Dimitrios Papadimoulis, Fabio De Masi, Marina Albiol Guzmán, Barbara Spinelli and Rina Ronja Kari, on behalf of the GUE/NGL Group, on endocrine disruptors: state of play following the Court of Justice judgment of 16 December 2015 (2016/2747(RSP)) (B8-0735/2016);

—   Piernicola Pedicini, Marco Affronte, Eleonora Evi, Marco Zullo, Fabio Massimo Castaldo, Marco Valli, Daniela Aiuto, Laura Agea, Dario Tamburrano, Laura Ferrara, Isabella Adinolfi, Tiziana Beghin, David Borrelli, Rosa D’Amato, Ignazio Corrao and Marco Zanni, on behalf of the EFDD Group, on endocrine disruptors: state of play following the Court of Justice judgment of 16 December 2015 (2016/2747(RSP)) (B8-0736/2016);

—   Jens Gieseke, on behalf of the PPE Group, and Julie Girling, on behalf of the ECR Group, on endocrine disruptors: state of play following the Court of Justice judgment of 16 December 2015 (2016/2747(RSP)) (B8-0737/2016);

—   Gerben-Jan Gerbrandy, on behalf of the ALDE Group, on endocrine disruptors: state of play following the Court of Justice judgment of 16 December 2015 (2016/2747(RSP)) (B8-0738/2016).

Vote: minutes of 8.6.2016, item 12.18.